Diagnostic and Management Pathways for Pulmonary Carcinoid Tumours in the United Kingdom: Results from the National Lung Neuroendocrine Tumour Pathway Project

Figure 1

Reported use of tests and investigations at diagnosis. Any version. Bars represent the percentage of respondents reporting use of tests/investigations at their centre; the remainder reported either ‘no’ (i.e., test not used) or ‘not known.’ Abbreviations: 5-HIAA, 5-hydroxyindoleacetic acid; CT TAP, computed tomography of thorax, abdomen, and pelvis; FDG, fluorodeoxyglucose; PET, positron emission tomography; SRS, somatostatin receptor scintigraphy; TNM, tumour node metastasis; WHO, World Health Organisation.